Safer, More Effective CAR T-Cell Therapy Development With Proteomics Insights from NGS-Based Platforms

In this webinar, Marco Ruella, MD, shares key translational insights from his research program, highlighting ongoing efforts to enhance CAR T-cell function, mitigate adverse events, and expand the therapeutic potential of adoptive cell therapies.